Wild-type (senile) amyloidosis electrocardiogram: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 31: Line 31:
  | doi = 10.1136/openhrt-2015-000289
  | doi = 10.1136/openhrt-2015-000289
  | pmid = 26870387
  | pmid = 26870387
}}</ref><ref>{{Cite journal
| author = [[Esther Gonzalez-Lopez]], [[Christian Gagliardi]], [[Fernando Dominguez]], [[Cristina Candida Quarta]], [[F. Javier de Haro-Del Moral]], [[Agnese Milandri]], [[Clara Salas]], [[Mario Cinelli]], [[Marta Cobo-Marcos]], [[Massimiliano Lorenzini]], [[Enrique Lara-Pezzi]], [[Serena Foffi]], [[Luis Alonso-Pulpon]], [[Claudio Rapezzi]] & [[Pablo Garcia-Pavia]]
| title = Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths
| journal = [[European heart journal]]
| volume = 38
| issue = 24
| pages = 1895–1904
| year = 2017
| month = June
| doi = 10.1093/eurheartj/ehx043
| pmid = 28329248
}}</ref>
}}</ref>
:*Poor R wave progression<ref>{{Cite journal
| author = [[Esther Gonzalez-Lopez]], [[Christian Gagliardi]], [[Fernando Dominguez]], [[Cristina Candida Quarta]], [[F. Javier de Haro-Del Moral]], [[Agnese Milandri]], [[Clara Salas]], [[Mario Cinelli]], [[Marta Cobo-Marcos]], [[Massimiliano Lorenzini]], [[Enrique Lara-Pezzi]], [[Serena Foffi]], [[Luis Alonso-Pulpon]], [[Claudio Rapezzi]] & [[Pablo Garcia-Pavia]]
| title = Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths
| journal = [[European heart journal]]
| volume = 38
| issue = 24
| pages = 1895–1904
| year = 2017
| month = June
| doi = 10.1093/eurheartj/ehx043
| pmid = 28329248
}}</ref>
:*Atrial fibrillation<ref>{{Cite journal
| author = [[Christoph Rocken]], [[Brigitte Peters]], [[Gina Juenemann]], [[Wolfgang Saeger]], [[Helmut U. Klein]], [[Christof Huth]], [[Albert Roessner]] & [[Andreas Goette]]
| title = Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation
| journal = [[Circulation]]
| volume = 106
| issue = 16
| pages = 2091–2097
| year = 2002
| month = October
| doi = 10.1161/01.cir.0000034511.06350.df
| pmid = 12379579
}}</ref><ref>{{Cite journal
| author = [[Nicole B. Cyrille]], [[Jeff Goldsmith]], [[Julissa Alvarez]] & [[Mathew S. Maurer]]
| title = Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis
| journal = [[The American journal of cardiology]]
| volume = 114
| issue = 7
| pages = 1089–1093
| year = 2014
| month = October
| doi = 10.1016/j.amjcard.2014.07.026
| pmid = 25212550
}}</ref>





Revision as of 22:18, 17 December 2019

Wild-type (senile) amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Wild-type (senile) amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Wild-type (senile) amyloidosis electrocardiogram On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wild-type (senile) amyloidosis electrocardiogram

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wild-type (senile) amyloidosis electrocardiogram

CDC on Wild-type (senile) amyloidosis electrocardiogram

Wild-type (senile) amyloidosis electrocardiogram in the news

Blogs on Wild-type (senile) amyloidosis electrocardiogram

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Wild-type (senile) amyloidosis electrocardiogram

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Electrocardiogram

  • The EKG findings in wild-type (senile) amyloidosis have low sensitivity and specificity for the condition.[1]
  • This is because the EKG findings are also common in aging patients in the setting of comorbidities.
  • EKG findings encountered during the evaluation of a patient with wild-type (senile) amyloidosis are given below:
  • Pseudoinfarct pattern[2][3]
  • Poor R wave progression[4]
  • Atrial fibrillation[5][6]


References

  1. Ilia G. Halatchev, Jingsheng Zheng & Jiafu Ou (2018). "Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies". Journal of thoracic disease. 10 (3): 2034–2045. doi:10.21037/jtd.2018.03.134. PMID 29707360. Unknown parameter |month= ignored (help)
  2. Thibaud Damy, Mathew S. Maurer, Claudio Rapezzi, Violaine Plante-Bordeneuve, Onur N. Karayal, Rajiv Mundayat, Ole B. Suhr & Arnt V. Kristen (2016). "Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy". Open heart. 3 (1): e000289. doi:10.1136/openhrt-2015-000289. PMID 26870387.
  3. Esther Gonzalez-Lopez, Christian Gagliardi, Fernando Dominguez, Cristina Candida Quarta, F. Javier de Haro-Del Moral, Agnese Milandri, Clara Salas, Mario Cinelli, Marta Cobo-Marcos, Massimiliano Lorenzini, Enrique Lara-Pezzi, Serena Foffi, Luis Alonso-Pulpon, Claudio Rapezzi & Pablo Garcia-Pavia (2017). "Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths". European heart journal. 38 (24): 1895–1904. doi:10.1093/eurheartj/ehx043. PMID 28329248. Unknown parameter |month= ignored (help)
  4. Esther Gonzalez-Lopez, Christian Gagliardi, Fernando Dominguez, Cristina Candida Quarta, F. Javier de Haro-Del Moral, Agnese Milandri, Clara Salas, Mario Cinelli, Marta Cobo-Marcos, Massimiliano Lorenzini, Enrique Lara-Pezzi, Serena Foffi, Luis Alonso-Pulpon, Claudio Rapezzi & Pablo Garcia-Pavia (2017). "Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths". European heart journal. 38 (24): 1895–1904. doi:10.1093/eurheartj/ehx043. PMID 28329248. Unknown parameter |month= ignored (help)
  5. Christoph Rocken, Brigitte Peters, Gina Juenemann, Wolfgang Saeger, Helmut U. Klein, Christof Huth, Albert Roessner & Andreas Goette (2002). "Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation". Circulation. 106 (16): 2091–2097. doi:10.1161/01.cir.0000034511.06350.df. PMID 12379579. Unknown parameter |month= ignored (help)
  6. Nicole B. Cyrille, Jeff Goldsmith, Julissa Alvarez & Mathew S. Maurer (2014). "Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis". The American journal of cardiology. 114 (7): 1089–1093. doi:10.1016/j.amjcard.2014.07.026. PMID 25212550. Unknown parameter |month= ignored (help)